Suchergebnisse - "2494G1JF75"

PubPharm (403)

101

Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression : results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)

enthalten in: HIV clinical trials | 2009

von Nunes, E. | Santini de Oliveira, M. | Merçon, M. | +6

102

How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials

enthalten in: AIDS (London, England) | 2009

von Hill, A. | van der Lugt, J. | Sawyer, W. | +1

ErratumIn: AIDS. 2010 Mar 27;24(6):940

103

Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children

enthalten in: The Journal of antimicrobial chemotherapy | 2009

von Puthanakit, T. | van der Lugt, J. | Bunupuradah, T. | +8

CommentIn: J Antimicrob Chemother. 2010 Apr;65(4):808-9; author reply 809-10. - PMID 20086000

104

Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2009

von Boulanger, C. | Hollender, E. | Farrell, K. | +8

105

Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients

enthalten in: Pharmacogenomics | 2009

von Elens, L. | Yombi, J. | Lison, D. | +3

106

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy : results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2009

von Negredo, E. | Miró, O. | Rodríguez-Santiago, B. | +35

107

The CASTLE study : atazanavir/r versus lopinavir/r in antiretroviral-naive patients

enthalten in: Expert review of anti-infective therapy | 2009

von Chetchotisakd, P.

108

Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir

enthalten in: HIV clinical trials | 2009

von Rathbun, C. | Liedtke, M. | Blevins, S. | +4

109

Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure

enthalten in: BMC infectious diseases | 2009

von Hsieh, S. | Chang, S. | Hung, C. | +3

110

Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients

enthalten in: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) | 2009

von Pérez-Elías, M. | Moreno, A. | Casado, J. | +8